Search results
Results from the WOW.Com Content Network
Bayer AG (English: / ˈ b aɪ. ər /, commonly pronounced / ˈ b eɪ ər /; [3] German:) is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world.
Bayer Corporation (also known as Bayer USA) is the American subsidiary of Bayer AG. Its main offices are located in Whippany, New Jersey . In addition it has 40 fully consolidated subsidiary companies [ 3 ] located in 19 different states.
William Anderson (born August 23, 1966) is an American business executive who has been the chief executive officer (CEO) of Bayer AG since June 2023. [1] [2]Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.
The Bayer-Monsanto merger is widely considered to be one of the worst mergers in history, mostly due to the exposure to Roundup litigation. [ 109 ] [ 14 ] [ 15 ] [ 16 ] By 2023, Bayer's market value had declined by over 60% since its 2016 merger, leaving the company's overall worth at less than half of what it paid to acquire Monsanto.
Losses for Bayer investors reach tens of billions of Euros just two years after the acquisition. His position as CEO of Bayer was renewed in 2020 until 2024 before the general meeting of shareholders in 2021. [10] [11] [12] By 2023, Bayer investor DekaBank called for Baumann to be replaced ahead of his scheduled departure. [13]
Carro is the son of a Spanish teacher mother. [1] Carro grew up in Barcelona. He attended the German School of Barcelona, graduating in 1982.He then trained as a technical sales representative with BASF in Spain, and went on to study industrial engineering and management at the Karlsruhe Institute of Technology in Germany.
On January 17, 2020, WuXi Biologics and Bayer announced an acquisition agreement in which WuXi Biologics would take over the operations and lease a 139,931 sq ft (13,000.0 m 2) fill site in Leverkusen, Germany.
It is a Bayer spin-off formed in the fall of 2015 and was formerly called Bayer MaterialScience. [3] [4] Covestro shares were first offered on the Frankfurt Stock Exchange in October 2015. [5] Bayer sold its entire remaining stake in May 2018, Bayer's pension fund had a 6.8% stake managed separately. [6]